Schonfeld Strategic Advisors LLC Day One Biopharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $12.5 Billion
- Q2 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 99,590 shares of DAWN stock, worth $611,482. This represents 0.01% of its overall portfolio holdings.
Number of Shares
99,590
Previous 65,525
51.99%
Holding current value
$611,482
Previous $519,000
24.66%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DAWN
# of Institutions
188Shares Held
69.3MCall Options Held
127KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$39.5 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$37.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$27.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$25.2 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$22.9 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $451M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...